The upbeat data on manufacturing and services sectors follows similar surveys from Europe earlier in the day as businesses reopened after the health crisis resulted in a lockdown in mid-March
The World Health Organization reported a record rise in global coronavirus cases on Sunday, driving demand for perceived safe-havens, including gold and longer-term US Treasuries.
More than 119,000 Americans have perished from Covid-19 to date, according to Reuters' running tally.
The S&P 500 is on pace to finish the week with a 3.5 per cent gain, which would be its fourth in the last five weeks
'Every time the stock market starts to sell off, the Federal Reserve responds with some accommodative policy,' said Mike O'Rourke, chief market strategist at JonesTrading
The SGX Nifty is indicating an open at around 10,030 levels for the Nifty amid mixed global cues
The S&P 500 and the Dow reversed earlier gains and snapped a three-day winning streak. Tech shares led the Nasdaq into the black
All three major US stock indexes were sharply higher, and on course for their third consecutive daily gains
Battered shares of US airlines, casino operators and cruise operators slipped after attempting a rebound in recent weeks
The Dow Jones Industrial Average rose 531.25 points, or 2.11%, at the open to 25,659.42.
All that happened in the markets today
The S&P 500 was off as much as 0.8 per cent before the Fed statement
Zoom reported fiscal first-quarter revenue of $328.2 million, beating analysts' estimates of $202.7 million, according to IBES data from Refinitiv
US-traded Chinese technology firms such as JD.com and NetEase are looking for an alternative home closer to the mainland in case tensions between Washington and Beijing escalate
The benchmark index traded above the key psychological level for the first time since March 5
The S&P 500 rose 2.2 per cent to 3,020 points at the open
Berkshire Hathaway sold 84 per cent of its Goldman Sachs stock in the first quarter, marking a reversal for an investor who generally holds large stakes in the banking sector.
Drugmaker Moderna Inc surged 19.96 per cent after the company said its experimental COVID-19 vaccine showed promising results in a small early-stage trial
Investors have kept a close eye on vaccine programs of several drugmakers, cheering any positive development amid fears of a second wave of infections as governments start easing restrictions
Stocks have rebounded sharply since late March from the coronavirus-fueled sell-off, helped by massive monetary and fiscal stimulus